Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Siena

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Journal of the National Cancer Institute|August 3, 2000
Re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinomaP Pedrazzoli, A S Bianchi, M Renga, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF)M Bregni, S Siena, G Bonadonna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2018
Toxicity of oxaliplatin rechallenge in metastatic colorectal cancerG Mauri, K Bencardino, A Sartore-Bianchi, et al.
Journal of Neuro-Oncology|December 2, 2000
The effect of anticonvulsant drugs on blood levels of methotrexateM Riva, G Landonio, C A Defanti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapyS Siena, R Schiavo, P Pedrazzoli, et al.
Haematologica|October 1, 1989
[Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy]A M Gianni, M Bregni, S Siena, et al.
Pathologie-Biologie|November 1, 1992
The use of GM-CSF and peripheral blood stem cells (PBSC) minimises haematological toxicity following a myeloablative course of chemo-radiotherapyA M Gianni, S Siena, M Bregni, et al.
Annals of the New York Academy of Sciences|January 1, 1987
High sensitivity and specificity assay for detection of leukemia/lymphoma cells in human bone marrowM Bregni, S Siena, R Dalla-Favera, et al.
Journal of Chemotherapy (Florence, Italy)|February 4, 2005
High dose chemotherapy and hematopoietic progenitor cell transplantation for breast cancerP Pedrazzoli, E Tarenzi, C Tullio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2020
The DNA damage response pathway as a land of therapeutic opportunities for colorectal cancerG Mauri, S Arena, S Siena, et al.
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Journal of the National Cancer Institute|August 3, 2000
Re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinomaP Pedrazzoli, A S Bianchi, M Renga, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF)M Bregni, S Siena, G Bonadonna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2018
Toxicity of oxaliplatin rechallenge in metastatic colorectal cancerG Mauri, K Bencardino, A Sartore-Bianchi, et al.
Journal of Neuro-Oncology|December 2, 2000
The effect of anticonvulsant drugs on blood levels of methotrexateM Riva, G Landonio, C A Defanti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapyS Siena, R Schiavo, P Pedrazzoli, et al.
Haematologica|October 1, 1989
[Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy]A M Gianni, M Bregni, S Siena, et al.
Pathologie-Biologie|November 1, 1992
The use of GM-CSF and peripheral blood stem cells (PBSC) minimises haematological toxicity following a myeloablative course of chemo-radiotherapyA M Gianni, S Siena, M Bregni, et al.
Annals of the New York Academy of Sciences|January 1, 1987
High sensitivity and specificity assay for detection of leukemia/lymphoma cells in human bone marrowM Bregni, S Siena, R Dalla-Favera, et al.
Journal of Chemotherapy (Florence, Italy)|February 4, 2005
High dose chemotherapy and hematopoietic progenitor cell transplantation for breast cancerP Pedrazzoli, E Tarenzi, C Tullio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2020
The DNA damage response pathway as a land of therapeutic opportunities for colorectal cancerG Mauri, S Arena, S Siena, et al.
Pageof 17